Skip to content

CG Oncology CGON Price / book

Price / book at other companies

Pfizer logo
PfizerPFE
1.8×+0.2×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Gilead Sciences logo
Gilead SciencesGILD
7.4×+0.1×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
10.3×+7.2×
Tango Therapeutics logo
Tango TherapeuticsTNGX
7.6×+6.7×
Immunovant, Inc. logo
Immunovant, Inc.IMVT
5.9×+1.8×

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%
Enterprise value$5.36B+212%
P/S1,062.4×-1,596×

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

Based on the most recent quarter.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's price / book?
CG Oncology (CGON) reported price / book of 5.2× in Q1 2026.
How has CG Oncology's price / book changed year-over-year?
CG Oncology's price / book increased by 97.6% year-over-year, from 2.6× to 5.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.